Search results for “Anti-CEA Antibody” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 984 patents, we discovered top 309 key players by total patent application. Genentech, Inc., Immunomedics, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 15.45% of the total patent filing.
California, United States
Patent: 72
New Jersey, United States
Patent: 45
Switzerland
Patent: 35
New York, United States
Patent: 30
Hessen, Germany
Patent: 24
South Korea
Patent: 22
Indiana, United States
Patent: 19
Tokyo-to, Japan
Patent: 18
California, United States
Patent: 16
New York, United States
Patent: 14
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 24 patents, we discovered top 13 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Forty Seven, Inc., Agalimmune Ltd. are active in this area.
STARTUP
California, United States
Patent: 3
STARTUP
United Kingdom
Patent: 2
STARTUP
Massachusetts, United States
Patent: 2
STARTUP
California, United States
Patent: 2
STARTUP
France
Patent: 1
STARTUP
Tokyo-to, Japan
Patent: 1
STARTUP
Tokyo-to, Japan
Patent: 1
STARTUP
Oost-Vlaanderen, Belgium
Patent: 1
STARTUP
British Columbia, Canada
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 103 patents applied in the last 5 years. We discover 89 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Iteos Belgium SA, Daiichi Sankyo Co., Ltd. take 12.62% of patent filing during this period.
New York, United States
Patent: 5
Belgium
Patent: 4
New Jersey, United States
Patent: 4
Jiangsu Sheng, China
Patent: 4
United Kingdom
Patent: 3
Belgium
Patent: 3
Shanghai Shi, China
Patent: 2
Gyeonggi-do, South Korea
Patent: 2
Bayern, Germany
Patent: 2
California, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 103 patents in last 5 years, we discover 49 new entrants. Iteos Belgium SA, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Cancer Research Ventures Ltd. are the most active new entrants in this area.
Belgium
Patent: 4
Jiangsu Sheng, China
Patent: 4
United Kingdom
Patent: 3
Shanghai Shi, China
Patent: 2
Gyeonggi-do, South Korea
Patent: 2
California, United States
Patent: 2
STARTUP
California, United States
Patent: 2
ZURICH, Switzerland
Patent: 2
Massachusetts, United States
Patent: 2
California, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 127 patents, we discovered top 37 universities and scientific research institutions by total patent application. New York University, Keio University, King's College London are dominant in this area. They take 26.77% of the total patent filing.
New York, United States
Patent: 11
Tokyo-to, Japan
Patent: 3
United Kingdom
Patent: 2
New Hampshire, United States
Patent: 2
California, United States
Patent: 2
Tokyo-to, Japan
Patent: 2
Fukuoka-ken, Japan
Patent: 2
Delhi, India
Patent: 2
Bayern, Germany
Patent: 2
Sachsen, Germany
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: